Tscan Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $20k | 11k | 1.82 |
| 2025-06-30 | $581k | 400k | 1.45 |
| 2025-03-31 | $170k | 123k | 1.38 |
| 2024-12-31 | $279k | 92k | 3.04 |
| 2024-09-30 | $96k | 19k | 4.98 |
| 2024-06-30 | $74k | 13k | 5.85 |
| 2024-03-31 | $15k | 1.9k | 7.94 |
| 2023-12-31 | $8.3k | 1.4k | 5.83 |
| 2023-09-30 | $2.9k | 1.1k | 2.56 |
| 2023-06-30 | $2.8k | 1.1k | 2.50 |
| 2023-03-31 | $6.8k | 3.2k | 2.10 |
| 2022-12-31 | $1.6k | 1.0k | 1.55 |
| 2022-09-30 | $11k | 3.4k | 3.20 |
| 2022-06-30 | $4.0k | 1.1k | 3.48 |
| 2021-12-31 | $4.0k | 811 | 4.93 |
| 2021-09-30 | $8.0k | 946 | 8.46 |